WS
LMAT icon

Wedbush Securities’s LeMaitre Vascular LMAT Stock Holding History

Wedbush Securities’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,915
Closed -$209K – 1345
2026
Q1 		$209K Buy
+1,915
New +$183K 0.01% 1110
2025
Q4 		– Sell
-2,357
Closed -$206K – 1239
2025
Q3 		$206K Sell
2,357
-283
-11% -$25.3K 0.01% 1062
2025
Q2 		$219K Buy
2,640
+20
+0.8% +$1.67K 0.01% 1015
2025
Q1 		$220K Sell
2,620
-305
-10% -$28.4K 0.01% 965
2024
Q4 		$270K Buy
+2,925
New +$281K 0.01% 871

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wedbush Securities's LMAT Position: Q2 2026 in Review

Wedbush Securities sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 1,915 shares — an estimated $209K sold.

Wedbush Securities first reported a position in LMAT in Q4 2024 and held it in 5 quarters. The position peaked at $270K in Q4 2024. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Wedbush Securities reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Wedbush Securities sold 1,915 LeMaitre Vascular shares in Q2 2026, an estimated $209K.
  • Wedbush Securities first reported a position in LeMaitre Vascular in Q4 2024 and held it in 5 quarters.
  • Wedbush Securities's LeMaitre Vascular position peaked at $270K in Q4 2024.
  • 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Wedbush Securities's 13F filing for Q2 2026, filed 28 Jul 2026.